03 Profile
Hansard to 12 November 2026 · 31,484 contributions indexed · 1,439 MPs & peers
All voices01 Voice · Clinician · Respiratory (asthma/COPD)
Philip Molyneaux
Consultant Respiratory Physician and Professor of Interstitial Lung Disease at Imperial College London
Quoted in the press, across 1 topic since 10 Jul 2026
02 Quoted on · 1 of 29 topics
Philip Molyneaux: key facts
- Kind of voice
- Clinician
- Role
- Consultant Respiratory Physician and Professor of Interstitial Lung Disease at Imperial College London
- Quoted on
- Respiratory (asthma/COPD)
- Press coverage
- Quoted in the press
- Most recently quoted
- 10 Jul 2026
04 On the record · press
What Philip Molyneaux has said
- pmlive.com
Where Philip Molyneaux has been quoted
- Boehringer Ingelheim's Jascayd approved by MHRA for idiopathic pulmonary fibrosispmlive.com · 10 Jul 2026
How we found the articles that name Philip Molyneaux: we searched news for these terms.
- asthma
- COPD
- respiratory disease
- lung cancer screening
- pulmonary
Also searched with “asthma” in each of 8 national papers, and in the Guardian by editor tag, and in trade press by category. Every term for Respiratory (asthma/COPD)
Verbatim
“A diagnosis of progressive pulmonary fibrosis means that life expectancy is reduced while day-to-day quality of life can often deteriorate, as breathlessness and fatigue worsen.”
Related media coverage
Recent UK press coverage of their topics, not necessarily citing them directly.
- Asthma Salbutamol blue inhaler reminder as pharmacist issues messageWales Online
- UK pharmacist Salbutamol reminder for anyone taking blue inhaler for asthmaThe Mirror
- Fallowfield Grandad shares shock at being diagnosed with lung cancer despite having no symptoms – now he’s helping scientists look for cancer clues hidden in bloodAbout Manchester
Doctors, nurses, allied health professionals and other registered clinicians quoted in a clinical capacity. Citations are counted by an automated scan of UK press coverage and may be incomplete. Roles, biographies and contact details are researched and human-reviewed before they appear here; anything not yet reviewed is simply absent rather than shown unverified. This profile was last updated on 13 Nov 2026. See the methodology for how this page is built, or email contact@bridgeheadcommunications.com to correct anything on it.